Chicago Partners Investment Group LLC Buys Shares of 10,954 Septerna, Inc. (NASDAQ:SEPN)

Chicago Partners Investment Group LLC bought a new stake in Septerna, Inc. (NASDAQ:SEPN) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 10,954 shares of the company’s stock, valued at approximately $63,000.

Other large investors have also recently bought and sold shares of the company. Tower Research Capital LLC TRC bought a new stake in Septerna in the fourth quarter valued at approximately $25,000. Legal & General Group Plc bought a new stake in Septerna in the fourth quarter valued at approximately $42,000. Summit Investment Advisors Inc. bought a new stake in Septerna in the fourth quarter valued at approximately $45,000. KLP Kapitalforvaltning AS bought a new stake in Septerna in the first quarter valued at approximately $49,000. Finally, BNP Paribas Financial Markets bought a new stake in Septerna in the fourth quarter valued at approximately $52,000.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on SEPN shares. HC Wainwright started coverage on shares of Septerna in a research report on Monday, June 23rd. They set a “buy” rating and a $26.00 price objective for the company. Cantor Fitzgerald increased their price objective on shares of Septerna from $20.00 to $25.00 and gave the stock an “overweight” rating in a research report on Friday, May 16th. Finally, Wells Fargo & Company increased their price objective on shares of Septerna from $11.00 to $18.00 and gave the stock an “equal weight” rating in a research report on Friday, May 16th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, Septerna has a consensus rating of “Moderate Buy” and a consensus price target of $26.75.

Septerna Stock Down 2.5%

Shares of SEPN stock opened at $11.20 on Wednesday. The company has a market capitalization of $499.07 million and a price-to-earnings ratio of -1.11. Septerna, Inc. has a 12-month low of $4.17 and a 12-month high of $28.99. The firm has a fifty day moving average of $11.44 and a 200-day moving average of $9.25.

Septerna (NASDAQ:SEPN) last released its earnings results on Monday, August 11th. The company reported ($0.56) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.51). The business had revenue of $0.12 million during the quarter, compared to the consensus estimate of $22.50 million. Septerna had a negative net margin of 12,053.03% and a negative return on equity of 35.82%. On average, equities analysts expect that Septerna, Inc. will post -7.11 EPS for the current year.

Septerna Profile

We are a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by our proprietary Native Complex Platform™. Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of our deep pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases.